已收盤 05-08 16:00:00 美东时间
-5.070
-6.00%
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
This whale alert can help traders discover the next big trading opportunities. ...
05-05 01:35
今日重点评级关注:Benchmark:维持史密斯微软件"买入"评级,目标价从2美元升至2.5美元;Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元
05-04 16:04
RBC Capital analyst Logan Reich maintains Cava Group (NYSE:CAVA) with a Outperform and raises the price target from $90 to $100.
05-02 00:06
今日重点评级关注:HC Wainwright & Co.:维持Century Therapeutics"买入"评级,目标价从2美元升至5美元;Oppenheimer:维持Climb Bio"跑赢大市"评级,目标价从10美元升至18美元
04-22 12:41
今日重点评级关注:Canaccord Genuity:维持Vertical Aerospace"买入"评级,目标价从9.5美元升至10.5美元;Canaccord Genuity:维持AtaiBeckley Inc."买入"评级,目标价从14美元升至15美元
04-21 11:25
Shares of restaurant and food related companies are trading higher after Iran s...
04-18 01:06
CAVA shares rise as the Mediterranean chain enters St. Louis. With a new Cottleville site, CAVA eyes 1,000 locations by 2032. Read more now.
04-17 23:22
CAVA (NYSE:CAVA), the category-defining Mediterranean fast-casual restaurant brand, opened its doors today at 4765 B Hwy N, Cottleville, MO 63304. CAVA Cottleville is a 2,900-square-foot restaurant featuring a bright,
04-17 20:03
今日重点评级关注:HC Wainwright & Co.:维持Solaris Resources"买入"评级,目标价从16美元升至18美元;Leerink Partners:维持Spyre Therapeutics"跑赢大市"评级,目标价从49美元升至106美元
04-14 10:44